The stock of Mustang Bio Inc (NASDAQ:MBIO) last traded at $2.66, down -20.36% from the previous session.
MBIO stock price is now 110.86% away from the 50-day moving average and -52.63% away from the 200-day moving average. The market capitalization of the company currently stands at $11.65M.
With the price target of $11, BTIG Research recently initiated with Buy rating for Mustang Bio Inc (NASDAQ: MBIO). On October 02, 2020, B. Riley FBR recently initiated its ‘Buy’ rating on the stock quoting a target price of $9, while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’
A total of 28.11% of the company’s stock is owned by insiders.
During the past 12 months, Mustang Bio Inc has had a low of $0.89 and a high of $25.00. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.34, and a quick ratio of 1.34. The fifty day moving average price for MBIO is $1.2615 and a two-hundred day moving average price translates $5.615735 for the stock.
The latest earnings results from Mustang Bio Inc (NASDAQ: MBIO) was released for 2025-03-31. The company reported revenue of $0.25 million for the quarter, compared to $5.23 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -95.16 percent.
